News
SIRT with 90Y resin microspheres led to durable disease control in patients with gastrointestinal stromal tumor liver ...
Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, ...
Q1 2025 Earnings Conference Call April 29, 2025 8:00 AM ETCompany ParticipantsSloan Simpson - Head of Investor ...
The study also found that patients with faster-growing CML were less likely to respond well to tyrosine kinase inhibitors (TKIs) – the standard treatment ... presentation is several decades. This work ...
Patients with two or more prior ROS1 TKIs and one or more prior lines of ... Of course, things do not work that simply all the time. Diagnosis seems to work better with ALK+ NSCLC, so market ...
TKIs such as sunitinib target imatinib-resistant ... that appeared promising in early research or clinical trials do not demonstrate safety and/or efficacy in later preclinical studies or clinical ...
Hosted on MSN28d
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC"Brain metastases are very often detected on screening MRI, which is part of the standard work-up for patients with ... of EGFR tyrosine kinase inhibitors (TKIs). "The silver lining, so to speak ...
With regards to ‘adjuvant’ pembrolizumab or sunitinib, she argued that this patient has already been treated with systemic therapy and, thus, does not meet the eligibility ... 6 There is ongoing work ...
Panelists discuss how cardiovascular toxicity remains a significant concern with certain tyrosine kinase inhibitors (TKIs) ...
How do the Penn Relays work with competitors at all levels? Find out how ahead of the event starting on April 24. The 2025 Penn Relays is one of the oldest and most famous track and field meets in ...
Consumers Unified, LLC does not take loan or mortgage applications or make credit decisions. Rather, we display rates from lenders that are licensed or otherwise authorized to work in Vermont.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results